Factors associated with readmission after minimally invasive transforaminal lumbar interbody fusion

Luis M Tumialán1, Nolan Weinstein2, S Harrison Farber1

  • 11Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.

Abstract

Insights

Living alone and diabetes predict 30-day readmission after minimally invasive surgery (MIS) for transforaminal lumbar interbody fusion (TLIF). Female sex, diabetes, and multilevel surgery predict prolonged hospital stays.

Area of Science:

  • Neurosurgery
  • Spinal Surgery
  • Minimally Invasive Procedures

Background:

  • Minimally invasive surgery (MIS) for transforaminal lumbar interbody fusion (TLIF) offers potential benefits.
  • Identifying factors influencing hospital length of stay (LOS) and 30-day readmission is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To identify predictors of prolonged hospital stay and 30-day readmission following MIS TLIF.
  • To inform strategies for reducing readmission rates and LOS.

Main Methods:

  • Retrospective analysis of 174 consecutive patients undergoing MIS TLIF between January 2016 and March 2018.
  • Data collected included demographics, operative details, and outcomes (LOS, 30-day readmission).
  • Regression analyses were used to identify significant predictors.

Main Results:

  • Mean LOS was 1.8 days; 6% of patients were readmitted within 30 days.
  • Living alone and diabetes were significant predictors of readmission (p=0.04).
  • Female sex, diabetes, and multilevel surgery predicted LOS > 3 days (p<0.05).

Conclusions:

  • Common causes for readmission included urinary retention, constipation, and persistent symptoms.
  • Social factors, such as living alone, contributed to prolonged LOS.
  • Proactive management of identified risk factors may improve outcomes after MIS TLIF.

Related Concept Videos